KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Return on Equity: 2010-2025

Historic Return on Equity for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Sep 2025 value amounting to 0.15%.

  • Regeneron Pharmaceuticals' Return on Equity fell 1.00% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year decrease of 1.00%. This contributed to the annual value of 0.16% for FY2024, which is negligibly% changed negligibly from last year.
  • Regeneron Pharmaceuticals' Return on Equity amounted to 0.15% in Q3 2025, which was up 0.03% from 0.15% recorded in Q2 2025.
  • Regeneron Pharmaceuticals' 5-year Return on Equity high stood at 0.46% for Q2 2021, and its period low was 0.15% during Q1 2024.
  • Moreover, its 3-year median value for Return on Equity was 0.16% (2023), whereas its average is 0.16%.
  • As far as peak fluctuations go, Regeneron Pharmaceuticals' Return on Equity grew by 18bps in 2021, and later dropped by 25bps in 2022.
  • Regeneron Pharmaceuticals' Return on Equity (Quarterly) stood at 0.45% in 2021, then fell by 25bps to 0.20% in 2022, then decreased by 4bps to 0.16% in 2023, then fell by 1bps to 0.15% in 2024, then decreased by 1bps to 0.15% in 2025.
  • Its Return on Equity was 0.15% in Q3 2025, compared to 0.15% in Q2 2025 and 0.15% in Q1 2025.